L-Menthyl glyoxylate hydrate

We are L-Menthyl glyoxylate hydrate CAS:111969-64-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:L-Menthyl glyoxylate hydrate
CAS.NO:111969-64-3
Synonyms:L-Menthyl glyoxylate hydrate
2,2-Dihydroxyacetic Acid (1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl Ester
Glyoxylic acid (1S)-menthyl ester hydrate
L-Menthyl Glyoxylate Hydrate
L-Menthyl glyoxylate monohydrate
L-Menthyl 2,2-dihydroxyacetate
2,2-Dihydroxyacetic acid (-)-menthyl ester
 
Physical and Chemical Properties:
Density 1.09
Boiling Point 320°C
Melting Point 76-78°C
Molecular Formula C12H22O4
Molecular Weight 230.30100
Flash Point 113°C
Vapour Pressure 2.74E-05mmHg at 25°C
Index of Refraction 1.487
 
Specification:
Appearance:White to light yellow crystalline powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Lacosamide(CAS:175481-36-4).

L-Menthyl glyoxylate hydrate


Related News: The cell product candidate is being developed under a collaboration with Memorial Sloan Kettering Cancer Center (MSK) led by Michel Sadelain, MD, PhD.1243308-37-3 With the global industrial division of labor and the change in the business model of multinational pharmaceutical companies, the outsourced market for patented drug substances will further expand.3-Bromo-2-chloro-5-nitropyridine It is foreseeable that in the future, the capacity and output of bulk APIs in China will decrease, the supply-demand relationship will be balanced, and prices and profits will gradually return to a more reasonable range. The era of low prices in the past will be gone forever. Individual APIs Varieties may even lose their price competitive advantage and move abroad.2-hydroxy-3-propan-2-ylbenzoic acid CAS:7053-88-5 The company’s short-term plan is to move from a purely chemical intermediate manufacturer to a formula active material supplier, and its long-term goal is to become a solution provider in the selected segment. In the future, this business is expected to become a new growth point for the company’s profit.The program will run alongside our ongoing Phase 3 INSPIRE Trial, and is expected to continue until commercial launch in such countries.

Related Products
Product Name
2,4-Dihydroxybenzaldehyde View Details
Ethyl 3-[[3-amino-4-(methylamino)benzoyl]-pyridin-2-ylamino]propanoate View Details
2-Bromochlorobenzene View Details
N-(2-Pyrazinylcarbonyl)-L-phenylalanine manufacturer Methyl N-cyanoethanimideate manufacturer 7,8-Dimethoxy-3-(3-iodopropyl)-1,3-dihydro-2H-3-benzazepin-2-one manufacturer 9-bromonon-1-ene manufacturer 1-Bromo-2-methylbutane manufacturer